Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07465302 · ClinicalTrials.gov registry record · Phase 2
Treating Spinal Cord Injury With Early Normobaric Hyperoxia
A Phase 2 study, sponsored by University of Florida.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT07465302 is a Phase 2 study that is actively recruiting participants, run by University of Florida. The registered enrollment target is 12 participants.
The verdict
NCT07465302, a Phase 2 study, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
SpiCoH is a phase IIa, single center, open-label, clinical trial of intermittent normobaric hyperoxia in mechanically ventilated patients with traumatic cervical and/or thoracic spinal cord injury.
Interventions
- OTHER Normobaric Hyperoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2026-04-15 |
| Est. Completion | 2028-09-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07465302
The ClinicalTrials.gov registry entry for NCT07465302 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Normobaric Hyperoxia is the first listed.
NCT07465302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07465302 about?
NCT07465302 is a clinical study titled "Treating Spinal Cord Injury With Early Normobaric Hyperoxia". SpiCoH is a phase IIa, single center, open-label, clinical trial of intermittent normobaric hyperoxia in mechanically ventilated patients with traumatic cervical and/or thoracic spinal cord injury.
What is the current status of trial NCT07465302?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2026-04-15. Estimated completion is 2028-09-30.
What interventions are being tested in trial NCT07465302?
The interventions under investigation include: Normobaric Hyperoxia (OTHER).
Who is sponsoring clinical trial NCT07465302?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.